The main purpose of this legislation is to improve the response to opioid overdoses in federal correctional facilities by ensuring that opioid antagonists, such as naloxone, are readily available. The goal is to reduce the number of fatalities from opioid overdoses among incarcerated individuals by providing necessary medical resources and training.